Primary surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer

Primary surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer : a phase III randomized controlled study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035918

Enrollment

Unknown

Registered

2020-08-20

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

1:Surgery

2:Neoadjuvant chemotherapy

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Stage IV ovarian cancer; 2) Informed consent.

Exclusion criteria

Exclusion criteria: 1) Contraindication for primary surgery; 2) Contraindication for neoadjuvant chemotherapy.

Design outcomes

Primary

Measure	Time frame
PFS;	—

Countries

China

Contacts

Public ContactXiaohua Wu

Department of Gynecologic Oncology, Shanghai Cancer Center, Fudan University

wu.xh@fudan.edu.cn+86 13601772486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026